Cardlytics, Inc. — Director's Dealing 2020

Jun 17, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cardlytics, Inc. (CDLX)
CIK: 0001666071
Period of Report: 2020-06-16

Reporting Person: Grimes Scott D. (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-16	Common Stock	S	300	$71.69	Disposed	126812	Indirect
2020-06-16	Common Stock	S	560	$73.21	Disposed	126252	Indirect
2020-06-16	Common Stock	S	1140	$74.39	Disposed	125112	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	225166	Direct

Footnotes

F1: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustee of the 2013 Scott Grimes GRAT UAD (the "GRAT") on November 15, 2019, as amended March 12, 2020.

F2: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $71.40 to $72.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4) and (5) to this Form 4.

F3: The reportable securities are held by the GRAT.

F4: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $72.59 to $73.54, inclusive.

F5: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $73.88 to $74.72, inclusive.